HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

Transplant

Transplant

We’re here for you. Call us at 844-346-7222 or

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.

26 Clinical Trials
Transplant Phase III Accepting Patients
nct/study# NCT03800758 / EXPRESSIVE-HELPING-TRIAL

A Randomized Controlled Trial Testing Expressive Helping for Stem Cell Transplant Patients

Learn More
Transplant Phase II Accepting Patients
nct/study# NCT03601442 / MAP-PRO2018-0751

Managed Access Program (MAP) to Provide Access to CTL019, for ALL or DLBCL Patients With Out of Specification Leukapheresis Product and/or Manufactured Tisagenlecleucel Out of Specification for Commercial Release

Learn More
Transplant NA Accepting Patients
nct/study# NA / ARLG2-SCENE-Y8

Screening for Colonization with Resistant Enterobacterales in Neutropenic Patients with Hematologic Malignancies (SCENE)

Learn More
Transplant Phase I/II Accepting Patients
nct/study# NCT04482699 / RAPA501ALLOCOVID19

RAPA-501-ALLO-COVID-19, PI: Dr. Donato, Title: Phase I/Phase II Trial of Allogeneic Hybrid TREG/Th2 Cell (RAPA-501-Allo) Therapy for Severe, Post-Intubation Stage 3 COVID-19 Disease

Learn More
Transplant NA Accepting Patients
nct/study# NA / BB2121-EAP-001

EXPANDED ACCESS PROTOCOL (EAP) FOR SUBJECTS RECEIVING IDECABTAGENE VICLEUCEL THAT IS NONCONFORMING FOR COMMERCIAL RELEASE

Learn More
Transplant Phase I Accepting Patients
nct/study# NCT04220190 / RAPA-501-ALS

Phase I Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) for Amyotrophic Lateral Sclerosis

Learn More

We are here for you

For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.